These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34670224)

  • 1. Effects of dipeptidyl peptidase-4 inhibition on portal hypertensive and cirrhotic rats.
    Huang HC; Hsu SJ; Chuang CL; Hsiung SY; Chang CC; Hou MC; Lee FY
    J Chin Med Assoc; 2021 Dec; 84(12):1092-1099. PubMed ID: 34670224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats.
    Chang CC; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Chang T; Huang HC; Lee FY; Lee SD
    Eur J Pharmacol; 2017 May; 802():36-43. PubMed ID: 28238769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats.
    Brusilovskaya K; Königshofer P; Lampach D; Szodl A; Supper P; Bauer D; Beer A; Stift J; Timelthaler G; Oberhuber G; Podesser BK; Seif M; Zinober K; Rohr-Udilova N; Trauner M; Reiberger T; Schwabl P
    United European Gastroenterol J; 2020 Dec; 8(10):1174-1185. PubMed ID: 32878579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats.
    Pun CK; Huang HC; Chang CC; Chuang CL; Yen CH; Hsu SJ; Lee FY; Hou MC; Huang YH
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cediranib ameliorates portal hypertensive syndrome via inhibition of VEGFR-2 signaling in cirrhotic rats.
    Fan Q; Wu G; Chen M; Luo G; Wu Z; Huo H; Li H; Zheng L; Luo M
    Eur J Pharmacol; 2024 Feb; 964():176278. PubMed ID: 38158116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.
    Hu L; Su L; Dong Z; Wu Y; Lv Y; George J; Wang J
    J Mol Med (Berl); 2019 Mar; 97(3):423-434. PubMed ID: 30721324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DPP4 inhibitor reduces portal hypertension in cirrhotic rats by normalizing arterial hypocontractility.
    Wang X; Gu H; Li K; Lin J; Zhu Y; Deng W
    Life Sci; 2021 Nov; 284():119895. PubMed ID: 34450166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-Glucose Cotransporter-2 Inhibition Exacerbates Hepatic Encephalopathy in Biliary Cirrhotic Rats.
    Hsu SJ; Huang HC; Pun CK; Chang CC; Chuang CL; Huang YH; Hou MC; Lee FY
    J Pharmacol Exp Ther; 2022 Oct; 383(1):25-31. PubMed ID: 35926870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beneficial effects of curcumin in cirrhotic rats with portal hypertension.
    Hsu SJ; Lee JY; Lin TY; Hsieh YH; Huang HC; Lee FY; Lin HC; Hou MC; Lee SD
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes.
    Hsin IF; Huang HC; Chang CC; Hsu SJ; Lee FY; Huo TI; Chuang CL; Hou MC; Lee SD
    Clin Sci (Lond); 2018 Nov; 132(22):2391-2405. PubMed ID: 30348829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved hemodynamic and liver function in portal hypertensive cirrhotic rats after administration of B. pseudocatenulatum CECT 7765.
    Gómez-Hurtado I; Zapater P; Portune K; Juanola O; Fernández-Iglesias A; González-Navajas JM; Gracia-Sancho J; Sanz Y; Francés R
    Eur J Nutr; 2019 Jun; 58(4):1647-1658. PubMed ID: 29748815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Droxidopa, an oral norepinephrine precursor, improves hemodynamic and renal alterations of portal hypertensive rats.
    Coll M; Rodriguez S; Raurell I; Ezkurdia N; Brull A; Augustin S; Guardia J; Esteban R; Martell M; Genescà J
    Hepatology; 2012 Nov; 56(5):1849-60. PubMed ID: 22610782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sirolimus on liver cirrhosis and hepatic encephalopathy of common bile duct-ligated rats.
    Wu KC; Huang HC; Chang T; Lee WS; Chuang CL; Hsin IF; Hsu SJ; Lee FY; Chang CC; Lee SD
    Eur J Pharmacol; 2018 Apr; 824():133-139. PubMed ID: 29444470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin response and shunting modulation in cirrhotic rats by chronic nitric oxide inhibition.
    Huang HC; Wang SS; Lee FY; Chang CC; Chang FY; Lin HC; Hou MC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e265-9. PubMed ID: 17764528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
    Schwabl P; Payer BA; Grahovac J; Klein S; Horvatits T; Mitterhauser M; Stift J; Boucher Y; Trebicka J; Trauner M; Angermayr B; Fuhrmann V; Reiberger T; Peck-Radosavljevic M
    J Hepatol; 2014 Jun; 60(6):1135-42. PubMed ID: 24530596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension.
    Lin HC; Yang YY; Tsai TH; Huang CM; Huang YT; Lee FY; Liu TT; Lee SD
    J Hepatol; 2011 Jun; 54(6):1145-53. PubMed ID: 21145843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine deteriorates intrahepatic derangement and portal-systemic collaterals in cirrhotic rats.
    Tung HC; Hsu SJ; Tsai MH; Lin TY; Hsin IF; Huo TI; Lee FY; Huang HC; Ho HL; Lin HC; Lee SD
    Clin Sci (Lond); 2017 Jan; 131(1):69-86. PubMed ID: 27803296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats.
    Huang HC; Wang SS; Hsin IF; Chang CC; Lee FY; Lin HC; Chuang CL; Lee JY; Hsieh HG; Lee SD
    Hepatology; 2012 Jul; 56(1):248-58. PubMed ID: 22290687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
    Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual angiotensin receptor and neprilysin inhibitor reduced portal pressure through peripheral vasodilatation and decreasing systemic arterial pressure in cirrhotic rats.
    Pun CK; Chang CC; Chuang CL; Huang HC; Hsu SJ; Huang YH; Hou MC; Lee FY
    J Chin Med Assoc; 2023 Sep; 86(9):786-794. PubMed ID: 37462441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.